Llwytho...

Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model

BACKGROUND: Influenza B virus infections remain insufficiently studied and antiviral management in immunocompromised patients is not well defined. The treatment regimens for these high-risk patients, which have elevated risk of severe disease-associated complications, require optimization and can be...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Antimicrob Chemother
Prif Awduron: Pascua, Philippe Noriel Q, Marathe, Bindumadhav M, Vogel, Peter, Webby, Richard J, Govorkova, Elena A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477984/
https://ncbi.nlm.nih.gov/pubmed/30715325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky560
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!